Insiders · Profile

Walker Karen Marie

Chief Technology Officer at Kyverna Therapeutics. Filing since 15 Dec 2025. CIK 0002008556

Company
Date
Role
Action
Shares
Amount
Of holding
15 Dec 2025
Chief Technology Officer
Sold on a plan
23,998
$292.78K
51.5%
1 decision on file.